organization1 mention

KKR

Connected entities

organizationSpero Therapeutics organizationThomson Reuters

Appears in 2 topic(s)

● Importantworld1 outletCalibrating

Thomson Reuters to sell 51% stake in global print business to KKR for $500 million

Jul 14, 12:43upd. 8m

6.0Significance

1 source6.0Source trust

world1 outletCalibrating

Spero Therapeutics shares fall after $105M KKR deal

Spero Therapeutics, a biotech company, received a big investment from KKR. The company's shares went down after the deal. This deal is worth $105 million.

Jul 14, 10:20upd. 8m

5.8Significance

1 source6.0Source trust